p185(erB-2) and p180(erB-4) are epidermal growth factor (EGF) receptor-like tyrosine kinases, whose co-expression is observed in many breast carcinomas. Heregulins (HRGs), which contain an immunoglobulin unit and an EGF-like domain, bind to p180(erB-4) and activate p180(erB-4) and p185(erbB-2) through transphosphorylation or receptor heterodimerization. The EGF-like domain is sufficient for the activation. Despite the sequence similarity, no cross activity is seen between the p180(erbB-4) ligands (HRGs) and the p170(erbB-1) ligands [EGF and transforming growth factor (TGF)-α]. To investigate the structural basis of receptor specificity, we have determined the solution structure of the EGF-like domain of HRG-α by two-dimensional 1H nuclear magnetic resonance spectroscopy and simulated annealing calculations. Though its main-chain fold is similar to those of EGF and TGF-α, distinctive structural features are observed on the molecular surface including an ionic cluster and hydrophobic patches, which afford HRG-α the specific affinity for p180(erbB-4). The structure should provide a basis for the structure - activity relationship of HRGs and for the design of drugs which prevent progression of breast cancer.
|Number of pages||7|
|Publication status||Published - 1994|
All Science Journal Classification (ASJC) codes
- Molecular Biology
- Biochemistry, Genetics and Molecular Biology(all)
- Immunology and Microbiology(all)